Abt Associates: Bold thinkers driving real-world impact
Tuberculosis is one of the most difficult diseases to cure because of its lengthy drug treatment regimen. The shortest TB treatment requires a daily dose of medication for at least six months. Patients with multi-drug resistant TB face the even more daunting task of taking medicine daily for up to two years.
Abt Associates is a mission-driven, global leader in research and program implementation in the fields of health, social and environmental policy, and international development. Known for its rigorous approach to solving complex challenges, Abt Associates is regularly ranked as one of the top 20 global research firms and one of the top 40 international development innovators. The company has multiple offices in the U.S. and program offices in more than 40 countries.